St. Jude Medical eyes improved pacemaker sales this year

04/18/2013 | Medical Device & Diagnostic Industry online

St. Jude Medical is in the process of acquiring Nanostim, which will enable it to introduce a leadless pacemaker this year. The company also aims to release four other product lines. "[W]e expect steady improvement to the growth profile of our pacemaker business as we move through the remainder of 2013," CEO Daniel Starks said.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX